How Much Do PBMs Cost Hospices?

If you’ve ever tried to pin down your true PBM cost, you already know the answer isn’t simple.

On paper, pharmacy benefit managers (PBMs) look like cost-saving partners. In practice, the way they structure pricing, negotiate rebates, and manage prescription drug claims can quietly shape your hospice’s margins more than almost any other vendor relationship.

For hospice leaders operating under a fixed Medicare per-diem, every dollar spent on medications comes directly out of your operating margin. That makes understanding PBM cost less of an accounting exercise and more of a strategic imperative.

Let’s break it down clearly.

What Is Driving PBM Cost in Hospice?

Pharmacy benefit managers, often called PBMs, act as intermediaries between health plans, pharmacies, and drug manufacturers. In traditional markets, PBMs negotiate rebates, manage prescription drug benefits, and process prescription drug claims on behalf of plan sponsors and health insurers.

In hospice, the structure looks a little different.

A hospice PBM may:

• Contract with retail and mail order pharmacy networks
• Manage formularies
• Process claims
• Provide clinical oversight
• Offer utilization tools and reporting

All of that costs money. The question is how it’s priced and whether the structure aligns with your financial reality.

Unlike large health plans where prescription drug costs are offset by rebates and complex benefit designs, hospice organizations operate under a fixed daily reimbursement from Medicare or Medicaid. There’s no wiggle room. Pharmacy spend must fit inside that per-diem.

The Three Most Common PBM Pricing Models

Understanding your PBM cost starts with knowing which pricing structure you’re under.

1. Per-Diem or Bundled PBM Pricing

Some PBMs offer a flat per-patient per-day rate covering medications and services.

On the surface, this feels predictable. One number. One invoice. Fewer surprises.

But bundled models can hide risk. If utilization trends shift or higher-cost specialty drugs enter the picture, the PBM may narrow formularies or push financial exposure back onto the hospice through non-formulary pricing.

Predictability is helpful. Hidden guardrails are not.

2. PBM Spread Pricing

Spread pricing is where PBMs generated significant scrutiny in broader healthcare markets.

In this model, the PBM bills the hospice one price but reimburses the pharmacy a lower amount, keeping the difference as revenue. That difference is called the “spread.”

The challenge is transparency.

If you cannot see what the PBM paid the pharmacy versus what you were billed, you cannot accurately measure your true PBM cost. Spread pricing can inflate prescription drug costs without the hospice realizing where the margin is being absorbed.

For organizations already operating on thin margins, that opacity matters.

3. Pass-Through Pricing

In a pass-through model, the PBM passes the actual pharmacy acquisition and dispensing costs directly to the hospice and charges a clearly defined administrative fee per claim.

No hidden spread. No rebate retention games.

This structure gives hospice leaders something rare in pharmacy contracting: visibility.

With transparent claim-level data, you can:

• Evaluate drug selection trends
• Optimize formulary alignment
• Identify high-cost patterns
• Forecast pharmacy spend more accurately

When margins are tight, clarity becomes currency.

How Formulary Design Impacts PBM Cost

Formularies are more than drug lists. They are financial levers.

Some PBMs negotiate aggressively with drug manufacturers and pharmacies, particularly among the largest PBMs in the broader health insurance market. In hospice, however, restrictive formularies can create unintended consequences.

If a needed medication is excluded:

• The hospice may face high non-formulary rates
• Nurses spend more time on prior authorizations
• Clinical workflows slow down
• Patient comfort may be delayed

What looks like cost control on paper can increase operational burden and erode staff efficiency.

PBM cost is not just about drug prices. It’s about the downstream effect on your team.

Vertical Integration and Why It Matters

Many large PBMs operate under vertically integrated structures alongside health insurers, specialty pharmacies, and mail order pharmacy services.

In commercial insurance markets, this integration allows PBMs to negotiate rebates and manage benefit plans at scale. In hospice, however, the economics are different.

Hospices are not passing drug costs to members through premiums or cost sharing. You’re absorbing the expense inside a fixed reimbursement structure.

That makes it essential to ask:

• Are rebates passed through to the hospice?
• Are administrative fees clearly defined?
• Are there ownership relationships influencing pharmacy selection?

Without transparency, vertical integration can blur accountability.

The Real Impact of PBM Cost on Hospice Margins

Under the Medicare hospice benefit, organizations receive a set daily rate intended to cover all services, including medications related to the terminal diagnosis.

If pharmacy spend creeps upward because of opaque PBM services, the impact is immediate.

Higher drug spend means:

• Reduced operating margin
• Fewer resources for staffing
• Less flexibility for innovation
• Increased financial stress

Contrast that with a transparent model where clinical pharmacists are embedded in the workflow, helping deprescribe unnecessary medications and optimize regimens. 

When PBM structure supports clinical insight instead of obscuring costs, margins stabilize.

Transparency as a Strategic Advantage

Transparency allows hospice leaders to see:

• What the PBM paid the pharmacy
• What the hospice was billed
• Any administrative fees
• Shipping or dispensing markups
• Utilization trends over time

With that visibility, you can compare models, renegotiate contracts, and make data-driven decisions.

Technology plays a role here too. When pharmacy management isn’t siloed, leaders can evaluate true PBM cost within the broader operational picture.

Clarity reduces surprises. Surprises erode margins.

See how BetterRX can help your hospice understand PBM costs today.

FAQs About PBM Cost in Hospice

What is a PBM in hospice, and why does it cost money?

A hospice pharmacy benefit manager negotiates drug prices with pharmacies, processes prescription drug claims, manages formularies, and provides clinical and utilization tools for hospices.

Hospices pay PBMs because they handle pharmacy contracting, benefit management, and technology support that can reduce overall drug spend and staff burden.

How do PBMs typically charge hospices?

PBMs serving hospices usually use one or more structures:

• Per-diem bundled pricing
• Pass-through pricing with an administrative fee per claim
• Spread pricing, where the PBM retains the difference between what it bills and what it pays the pharmacy

Each structure produces a different PBM cost profile.

What is pass-through pricing, and how does it affect my costs?

In a pass-through model, the PBM passes the exact pharmacy acquisition and dispensing costs directly to the hospice and adds a clearly defined administrative fee per claim.

This removes hidden markups and allows hospices to benefit directly from improvements in drug selection, utilization, and shipping efficiency.

How do formulary decisions affect what I pay a PBM?

Restrictive formularies may exclude higher-cost medications, then charge steep non-formulary rates when those drugs are required.

This can increase total spend, add prior authorization burden, and raise nurse workload, indirectly increasing operational cost.

How does working with a PBM affect my overall hospice margins?

Under Medicare and Medicaid, hospices receive a fixed daily payment that must cover all services, including medications.

If PBM pricing is opaque or inflated, pharmacy spend can consume a disproportionate share of that per-diem. Transparent pricing models support predictable budgeting and stronger margins.

How can greater transparency lower my PBM cost?

Transparency allows you to see what was paid, what was billed, and where fees apply.

With that insight, hospices can:

• Compare PBM models
• Renegotiate contracts
• Optimize formularies
• Select lower-cost equivalents without compromising symptom management

Clarity empowers control.

Your PBM Contract Is a Margin Strategy

PBM cost in hospice is not just about the price of pills. It’s about structure, transparency, and alignment with your financial reality.

In a reimbursement model that leaves no room for waste, the wrong PBM structure quietly drains margin. The right one strengthens it.

If your organization cannot clearly explain how its PBM generates revenue, that’s your first red flag.

BetterRX believes pharmacy should be transparent, clinically integrated, and built specifically for hospice. When pharmacy management supports your team instead of complicating it, you protect margins and improve patient comfort at the same time. Learn more about BetterRX today. 

About BetterRX

BetterRX's mission is to radically change patient care by ending medication delays that cause needless suffering. BetterRX offers efficient ordering technology, medication tracking, real-time PPD & cost alerts, and committed local pharmacies. Learn more about BetterRX, our ConnectedRX technology, what makes us Better than a PBM, and our Pharmacy partnerships.